Pay in 4 interest-free payments of $5.16 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
OneSource Specialty Pharma, along with Orbicular Pharmaceutical Technologies, has received tentative approval from the US Food and Drug Administration (FDA) for an Abbreviated New Drug Application (ANDA) for a generic version of Ozempic (semaglutide injection)
Lead stored in bone has a biological half-life measured in decades it cannot be fully eliminated in a single program
May help address stress-induced cravings while providing antioxidant benefits
Byetta (exenatide) [package insert]
US$ 22.24
US$ 23.52
US$ 23.73
